Talk to Congress; OVAC Lobby Day April 25 and 26, 2006

Posted by Dusty Weaver on January 18th, 2006

Come to Washington, D.D. to learn about colorectal cancer advocacy and speak up for increased federal funding for cancer research, treatment and screening. C3 advocates will be part of the annual One Voice Against Cancer (OVAC) Lobby Day on Tuesday, April 25th and Wednesday, April 26th, 2006.

Advocates participating in the OVAC “Lobby Days” must pay for their own lodging and transportation to Washington, D.C. C3 and OVAC cover the registration fee and training costs.

Congressional visits provide a unique opportunity for advocates to share how cancer has touched their lives. Having strong C3 participation during OVAC Lobby Days helps us educate our policy makers in Washington about the need for additonal research funds for colorectal cancer.

Registration and hotel information will be posted on the C3 web site as soon as it is available. If you have questions or comments about Lobby Day, please contact the C3 office at 202-244-2906 or send an email to the C3 Grassroots Coordinator. You can also go to the C3 Advocates in Action message board to participate in discussions about Lobby Days and other advocacy issues.

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions.

C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond where appropriate.

For the best response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Search C3

Donate

Support C3 and the Lisa Fund for Research

Donate to C3

Donate to The Lisa Fund

Learn more about the Lisa Fund

Sign Our Petition

Guarantee access to colorectal cancer screening for all Americans who need it.

Get Involved

Subscribe to the C3 website

Get C3 news & updates

Get the latest articles in your email inbox or news reader as soon as they are published.

Subscribe